About Efgartigimod Alfa-fcab
            
            Class: | Monoclonal antibody (IgG1 Fc fragment)  
Use: | Treatment of generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody positive  
Adult dose: | 10 mg/kg administered as an intravenous infusion every 2 weeks; may be adjusted based on clinical response  
Pediatric dose: | Safety and efficacy have not been established in pediatric patients  
Side effects: | Headache, infusion-related reactions, nausea, fatigue, and increased risk of infections  
Cont
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (IgG1 Fc fragment)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody positive
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: ARGENX BV, Belgium
                    
                    
                    Package Size
                    1 Glass Vial (20 ml)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 39549.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        10 mg/kg administered as an intravenous infusion every 2 weeks; may be adjusted based on clinical response
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy have not been established in pediatric patients
                    
                 
                
                
                    
                        Side Effects
                    
                    Headache, infusion-related reactions, nausea, fatigue, and increased risk of infections
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Known hypersensitivity to efgartigimod or any component of the formulation; active infections
         
        
        
            
                Important Warnings
            
            Monitor for signs of infection; caution in patients with a history of recurrent infections; potential for infusion-related reactions; not recommended for use in patients with severe active infections
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.